Literature DB >> 16729030

Increased apoptosis, Huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington's disease subjects.

A Ciammola1, J Sassone, L Alberti, G Meola, E Mancinelli, M A Russo, F Squitieri, V Silani.   

Abstract

Mutated huntingtin (htt) is ubiquitously expressed in tissues of Huntington's disease (HD) patients. In the brain, the mutated protein leads to neuronal cell dysfunction and death, associated with formation of htt-positive inclusions. Given increasing evidence of abnormalities in HD skeletal muscle, we extensively analyzed primary muscle cell cultures from seven HD subjects (including two unaffected mutation carriers). Myoblasts from presymptomatic and symptomatic HD subjects showed cellular abnormalities in vitro, namely mitochondrial depolarization, cytochrome c release, increased caspase-3, -8, and -9 activities, and defective cell differentiation. Another notable feature was the formation of htt inclusions in differentiated myotubes. This study helps to advance current knowledge about the downstream effects of the htt mutation in human tissues. Further applications may include drug screening using this human cellular model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16729030     DOI: 10.1038/sj.cdd.4401967

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  40 in total

1.  Huntington's disease and mitochondrial alterations: emphasis on experimental models.

Authors:  Verónica Pérez-De la Cruz; Paul Carrillo-Mora; Abel Santamaría
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

2.  Truncated peroxisome proliferator-activated receptor-γ coactivator 1α splice variant is severely altered in Huntington's disease.

Authors:  Ashu Johri; Anatoly A Starkov; Abhishek Chandra; Thomas Hennessey; Abhijeet Sharma; Sara Orobello; Ferdinando Squitieri; Lichuan Yang; M Flint Beal
Journal:  Neurodegener Dis       Date:  2011-07-15       Impact factor: 2.977

3.  Mutant huntingtin impairs vesicle formation from recycling endosomes by interfering with Rab11 activity.

Authors:  Xueyi Li; Clive Standley; Ellen Sapp; Antonio Valencia; Zheng-Hong Qin; Kimberly B Kegel; Jennifer Yoder; Laryssa A Comer-Tierney; Miguel Esteves; Kathryn Chase; Jonathan Alexander; Nicholas Masso; Lindsay Sobin; Karl Bellve; Richard Tuft; Lawrence Lifshitz; Kevin Fogarty; Neil Aronin; Marian DiFiglia
Journal:  Mol Cell Biol       Date:  2009-09-14       Impact factor: 4.272

4.  Circadian dysfunction in the Q175 model of Huntington's disease: Network analysis.

Authors:  Benjamin Smarr; Tamara Cutler; Dawn H Loh; Takashi Kudo; Dika Kuljis; Lance Kriegsfeld; Cristina A Ghiani; Christopher S Colwell
Journal:  J Neurosci Res       Date:  2019-07-29       Impact factor: 4.164

5.  Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease.

Authors:  Joshua D Crapser; Joseph Ochaba; Neelakshi Soni; Jack C Reidling; Leslie M Thompson; Kim N Green
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

6.  Molecular characterization of skeletal muscle atrophy in the R6/2 mouse model of Huntington's disease.

Authors:  Pengxiang She; Zhiyou Zhang; Deanna Marchionini; William C Diaz; Thomas J Jetton; Scot R Kimball; Thomas C Vary; Charles H Lang; Christopher J Lynch
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-04-19       Impact factor: 4.310

7.  Monkey hybrid stem cells develop cellular features of Huntington's disease.

Authors:  Chuti Laowtammathron; Eric Ch Cheng; Pei-Hsun Cheng; Brooke R Snyder; Shang-Hsun Yang; Zach Johnson; Chanchao Lorthongpanich; Hung-Chih Kuo; Rangsun Parnpai; Anthony W S Chan
Journal:  BMC Cell Biol       Date:  2010-02-05       Impact factor: 4.241

Review 8.  Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis.

Authors:  Sylvette Ayala-Peña
Journal:  Free Radic Biol Med       Date:  2013-04-18       Impact factor: 7.376

9.  IGF-1 intranasal administration rescues Huntington's disease phenotypes in YAC128 mice.

Authors:  Carla Lopes; Márcio Ribeiro; Ana I Duarte; Sandrine Humbert; Frederic Saudou; Luís Pereira de Almeida; Michael Hayden; A Cristina Rego
Journal:  Mol Neurobiol       Date:  2013-12-18       Impact factor: 5.590

10.  Impaired PGC-1alpha function in muscle in Huntington's disease.

Authors:  Rajnish K Chaturvedi; Peter Adhihetty; Shubha Shukla; Thomas Hennessy; Noel Calingasan; Lichuan Yang; Anatoly Starkov; Mahmoud Kiaei; Milena Cannella; Jenny Sassone; Andrea Ciammola; Fernando Squitieri; M Flint Beal
Journal:  Hum Mol Genet       Date:  2009-05-21       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.